KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Preferred Shares Issued (2017 - 2018)

Historic Preferred Shares Issued for Arbutus Biopharma (ABUS) over the last 2 years, with Q1 2018 value amounting to $66.3 million.

  • Arbutus Biopharma's Preferred Shares Issued changed N/A to $66.3 million in Q1 2018 from the same period last year, while for Dec 2018 it was $66.3 million, marking a year-over-year increase of 3559.72%. This contributed to the annual value of $66.3 million for FY2018, which is 3559.72% up from last year.
  • As of Q1 2018, Arbutus Biopharma's Preferred Shares Issued stood at $66.3 million.
  • Arbutus Biopharma's 5-year Preferred Shares Issued high stood at $66.3 million for Q1 2018, and its period low was $48.9 million during Q4 2017.